Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Woodcock’s Role in Aducanumab’s Approval Must Be Investigated as Part of IG Probe

WASHINGTON -

Acting U.S. Food and Drug Administration (FDA) Commissioner Janet Woodcock announced today that she has asked the U.S. Department of Health and Human Services (HHS) Acting Inspector General (IG) to investigate the “interactions between Biogen and the FDA during the process leading to the decision to approve” aducanumab for treatment of Alzheimer’s disease. On January 28, Public Citizen sent a letter to Dr. Woodcock urging her to endorse our call for an HHS OIG investigation of this unprecedented, inappropriately close collaboration between the FDA and Biogen. Dr. Michael Carome, director of Public Citizen’s Health Research Group, released the following statement:

“Public Citizen welcomes Dr. Woodcock’s belated request for an independent IG investigation of her agency’s inappropriately close collaboration with Biogen, as we had urged her to do nearly six months ago.

“Such an investigation must be broad and determine when Dr. Woodcock first became aware of this collaboration and whether she ever specifically endorsed or facilitated it in any way. The IG also must examine how Dr. Woodcock fostered a culture within the FDA’s Center for Drug Evaluation and Research that permitted and encouraged such an inappropriate collaboration with regulated industry. Under her leadership over the past three decades, the relationship between the FDA and the pharmaceutical industry has grown ever cozier — resulting in regulatory capture of the agency by industry.

“It is also imperative that Congress proceed expeditiously with its own announced investigation of the FDA-Biogen collaboration to ensure a thorough assessment and public airing of the circumstances that lead to the FDA’s reckless and inexcusable decision to approve aducanumab.”

###

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

Weapons Industry's $10 Million Investment in Congress Could Yield 450,000% Return

"The military-industrial complex's campaign spending spree gives war profiteers an outsized influence over Pentagon funding votes," said a Public Citizen campaigner.

Jessica Corbett ·


Surging Prices Amid Ukraine War Have Pushed 71 Million People Worldwide Into Poverty

As the cost-of-living crisis intensifies, said one U.N. official, "the threat of increased social unrest grows by the day."

Julia Conley ·


Slamming Their Profits From 'Weapons of War,' House Panel Asks Gun CEOs to Testify

"Products sold by your company have been used for decades to carry out homicides and even mass murders," the Democratic chair of the House Oversight Committee told the top executives of three major gun makers.

Jake Johnson ·


Lee, Pocan File Amendment to Slash $100 Billion From US Military Budget

"For far too long, this country has put profits ahead of its people," said Rep. Barbara Lee. "Nowhere is that more apparent than in our Pentagon topline budget."

Jake Johnson ·


UK Tory Prime Minister Boris Johnson Resigns Amid Relentless Scandal

"Real change can only come when the Tories are swept away and replaced with a people's government to redistribute wealth and power," said former Labour Leader Jeremy Corbyn.

Jake Johnson ·

Common Dreams Logo